Last updated on April 2019

Investigating Idiopathic Pulmonary Fibrosis in Greece (INDULGE IPF)


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Pulmonary Fibrosis | Idiopathic Pulmonary Fibrosis
  • Age: Between 40 - 100 Years
  • Gender: Male or Female

Inclusion criteria:

  • Newly diagnosed (less than 6 months) or patients previously diagnosed with IPF (more than 6 months from baseline visit), based upon the consensus statement jointly issued by ATS/ERS/JRS/ALAT in 2011 (see Annexes 6 and 7 for HRCT and histological criteria in Annex 6)
  • Exclusion of other known causes of ILD (e.g., domestic and occupational environmental exposures, connective tissue disease, and drug toxicity)
  • Assessment of IPF based on HRCT or combinations of HRCT and surgical lung biopsy, if available
  • Age =40 years old at the time of inclusion
  • Written informed consent for participation in the registry
  • Patients that can be followed up further, during the scheduled study period

Exclusion criteria:

  • Expected lung transplantation within the following 6 months
  • Participation in clinical trials

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.